Table of Content

1. Preface
? ? 1.1. Market Definition and Scope
? ? 1.2. Market Segmentation
? ? 1.3. Key Research Objectives
? ? 1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Global Orthobiologics Market

4. Market Overview
? ? 4.1. Introduction
? ? ? ? 4.1.1. Segment Definition
? ? 4.2. Overview
? ? 4.3. Market Dynamics
? ? ? ? 4.3.1. Drivers
? ? ? ? 4.3.2. Restraints
? ? ? ? 4.3.3. Opportunities
? ? 4.4. Global Orthobiologics Market Analysis and Forecasts, 2017-2031
? ? ? ? 4.4.1. Market Revenue Projections (US$ Mn)

5. Key Insights
? ? 5.1. Technological Advancements in Orthobiologics
? ? 5.2. Incidence of Orthopedic Disorders
? ? 5.3. Regulatory Scenario, by Key Countries
? ? 5.4. Reimbursement Scenario, by Key Countries
? ? 5.5. Pricing Analysis of Orthobiologics
? ? 5.6. Pipeline Analysis
? ? 5.7. Overview of Most Effective Combinations of Orthobiologics products
? ? 5.8. COVID-19 Pandemic Impact Analysis

6. Global Orthobiologics Market Analysis and Forecasts, By Product
? ? 6.1. Introduction & Definition
? ? 6.2. Key Findings / Developments
? ? 6.3. Market Value Forecast By Product, 2017-2031
? ? ? ? 6.3.1. Demineralized Bone Matrix (DBM)
? ? ? ? 6.3.2. Hydroxyapatite (HAp)
? ? ? ? 6.3.3. Hyaluronic acid (HA)
? ? ? ? 6.3.4. Calcium Sulfate Matrix
? ? ? ? 6.3.5. ?-tricalcium phosphate (?-TCP)
? ? ? ? 6.3.6. ?-TCP + HAp
? ? ? ? 6.3.7. DBM + PLGA
? ? ? ? 6.3.8. Regenerative Medicine
? ? ? ? ? ? 6.3.8.1. PRP
? ? ? ? ? ? 6.3.8.2. BMAC
? ? ? ? ? ? 6.3.8.3. SVF
? ? ? ? ? ? 6.3.8.4. Others (Exosome, etc.)
? ? ? ? 6.3.9. Growth Factors
? ? ? ? ? ? 6.3.9.1. BMP2
? ? ? ? ? ? 6.3.9.2. FGF2
? ? ? ? ? ? 6.3.9.3. TGF beta
? ? ? ? ? ? 6.3.9.4. VEGF
? ? ? ? ? ? 6.3.9.5. Others (IGF, etc.)
? ? 6.4. Market Attractiveness By Product

7. Global Orthobiologics Market Analysis and Forecasts, By End-user
? ? 7.1. Introduction & Definition
? ? 7.2. Key Findings / Developments
? ? 7.3. Market Value Forecast By End-user, 2017-2031
? ? ? ? 7.3.1. Hospitals
? ? ? ? 7.3.2. Orthopedic Clinics
? ? ? ? 7.3.3. Others (ENT Clinics, etc.)
? ? 7.4. Market Attractiveness By End-user

8. Global Orthobiologics Market Analysis and Forecasts, By Region
? ? 8.1. Key Findings
? ? 8.2. Market Value Forecast By Region
? ? ? ? 8.2.1. Europe
? ? ? ? 8.2.2. India
? ? ? ? 8.2.3. Rest of the World
? ? 8.3. Market Attractiveness By Country/Region

9. Europe Orthobiologics Market Analysis and Forecast
? ? 9.1. Introduction
? ? ? ? 9.1.1. Key Findings
? ? 9.2. Market Value Forecast By Product, 2017-2031
? ? ? ? 9.2.1. Demineralized Bone Matrix (DBM)
? ? ? ? 9.2.2. Hydroxyapatite (HAp)
? ? ? ? 9.2.3. Hyaluronic acid (HA)
? ? ? ? 9.2.4. Calcium Sulfate Matrix
? ? ? ? 9.2.5. ?-tricalcium phosphate (?-TCP)
? ? ? ? 9.2.6. ?-TCP + Hap
? ? ? ? 9.2.7. DBM + PLGA
? ? ? ? 9.2.8. ?-TCP + PLGA
? ? ? ? 9.2.9. Regenerative Medicine
? ? ? ? ? ? 9.2.9.1. PRP
? ? ? ? ? ? 9.2.9.2. BMAC
? ? ? ? ? ? 9.2.9.3. SVF
? ? ? ? ? ? 9.2.9.4. Others (Exosome, etc.)
? ? ? ? 9.2.10. Growth Factors
? ? ? ? ? ? 9.2.10.1. BMP2
? ? ? ? ? ? 9.2.10.2. FGF2
? ? ? ? ? ? 9.2.10.3. TGF beta
? ? ? ? ? ? 9.2.10.4. VEGF
? ? ? ? ? ? 9.2.10.5. Others (IGF, etc.)
? ? 9.3. Market Value Forecast By End-user, 2017-2031
? ? ? ? 9.3.1. Hospitals
? ? ? ? 9.3.2. Orthopedic Clinics
? ? ? ? 9.3.3. Others (ENT Clinics, etc.)
? ? 9.4. Market Value Forecast By Country, 2017-2031
? ? ? ? 9.4.1. Germany
? ? ? ? 9.4.2. U.K.
? ? ? ? 9.4.3. France
? ? ? ? 9.4.4. Italy
? ? ? ? 9.4.5. Spain
? ? ? ? 9.4.6. Rest of Europe
? ? 9.5. Market Attractiveness Analysis
? ? ? ? 9.5.1. By Product
? ? ? ? 9.5.2. By End-user
? ? ? ? 9.5.3. By Country

10. India Orthobiologics Market Analysis and Forecast
? ? 10.1. Introduction
? ? ? ? 10.1.1. Key Findings
? ? 10.2. Market Value Forecast By Product, 2017-2031
? ? ? ? 10.2.1. Demineralized Bone Matrix (DBM)
? ? ? ? 10.2.2. Hydroxyapatite (HAp)
? ? ? ? 10.2.3. Hyaluronic acid (HA)
? ? ? ? 10.2.4. Calcium Sulfate Matrix
? ? ? ? 10.2.5. ?-tricalcium phosphate (?-TCP)
? ? ? ? 10.2.6. ?-TCP + HAp
? ? ? ? 10.2.7. DBM + PLGA
? ? ? ? 10.2.8. ?-TCP + PLGA
? ? ? ? 10.2.9. Regenerative Medicine
? ? ? ? ? ? 10.2.9.1. PRP
? ? ? ? ? ? 10.2.9.2. BMAC
? ? ? ? ? ? 10.2.9.3. SVF
? ? ? ? ? ? 10.2.9.4. Others (Exosome, etc.)
? ? ? ? 10.2.10. Growth Factors
? ? ? ? ? ? 10.2.10.1. BMP2
? ? ? ? ? ? 10.2.10.2. FGF2
? ? ? ? ? ? 10.2.10.3. TGF beta
? ? ? ? ? ? 10.2.10.4. VEGF
? ? ? ? ? ? 10.2.10.5. Others (IGF, etc.)
? ? 10.3. Market Value Forecast By End-user, 2017-2031
? ? ? ? 10.3.1. Hospitals
? ? ? ? 10.3.2. Orthopedic Clinics
? ? ? ? 10.3.3. Others (ENT Clinics, etc.)
? ? 10.4. Market Attractiveness Analysis
? ? ? ? 10.4.1. By Product
? ? ? ? 10.4.2. By End-user

11. Rest of the World Orthobiologics Market Analysis and Forecast
? ? 11.1. Introduction
? ? ? ? 11.1.1. Key Findings
? ? 11.2. Market Value Forecast By Product, 2017-2031
? ? ? ? 11.2.1. Demineralized Bone Matrix (DBM)
? ? ? ? 11.2.2. Hydroxyapatite (HAp)
? ? ? ? 11.2.3. Hyaluronic acid (HA)
? ? ? ? 11.2.4. Calcium Sulfate Matrix
? ? ? ? 11.2.5. ?-tricalcium phosphate (?-TCP)
? ? ? ? 11.2.6. ?-TCP + HAp
? ? ? ? 11.2.7. DBM + PLGA
? ? ? ? 11.2.8. ?-TCP + PLGA
? ? ? ? 11.2.9. Regenerative Medicine
? ? ? ? ? ? 11.2.9.1. PRP
? ? ? ? ? ? 11.2.9.2. BMAC
? ? ? ? ? ? 11.2.9.3. SVF
? ? ? ? ? ? 11.2.9.4. Others (Exosome, etc.)
? ? ? ? 11.2.10. Growth Factors
? ? ? ? ? ? 11.2.10.1. BMP2
? ? ? ? ? ? 11.2.10.2. FGF2
? ? ? ? ? ? 11.2.10.3. TGF beta
? ? ? ? ? ? 11.2.10.4. VEGF
? ? ? ? ? ? 11.2.10.5. Others (IGF, etc.)
? ? 11.3. Market Value Forecast By End-user, 2017-2031
? ? ? ? 11.3.1. Hospitals
? ? ? ? 11.3.2. Orthopedic Clinics
? ? ? ? 11.3.3. Others (ENT Clinics, etc.)
? ? 11.4. Market Attractiveness Analysis
? ? ? ? 11.4.1. By Product
? ? ? ? 11.4.2. By End-user

12. Competition Landscape
? ? 12.1. Market Player - Competition Matrix (By Tier and Size of companies)
? ? 12.2. Market Share Analysis By Company (2022)
? ? 12.3. Company Profiles
? ? ? ? 12.3.1. Arthrex, Inc.
? ? ? ? ? ? 12.3.1.1. Company Overview
? ? ? ? ? ? 12.3.1.2. Financial Overview
? ? ? ? ? ? 12.3.1.3. Product Portfolio
? ? ? ? ? ? 12.3.1.4. Business Strategies
? ? ? ? ? ? 12.3.1.5. Recent Developments
? ? ? ? 12.3.2. ATEC Spine, Inc.
? ? ? ? ? ? 12.3.2.1. Company Overview
? ? ? ? ? ? 12.3.2.2. Financial Overview
? ? ? ? ? ? 12.3.2.3. Product Portfolio
? ? ? ? ? ? 12.3.2.4. Business Strategies
? ? ? ? ? ? 12.3.2.5. Recent Developments
? ? ? ? 12.3.3. Bioventus
? ? ? ? ? ? 12.3.3.1. Company Overview
? ? ? ? ? ? 12.3.3.2. Financial Overview
? ? ? ? ? ? 12.3.3.3. Product Portfolio
? ? ? ? ? ? 12.3.3.4. Business Strategies
? ? ? ? ? ? 12.3.3.5. Recent Developments
? ? ? ? 12.3.4. Exactech, Inc.
? ? ? ? ? ? 12.3.4.1. Company Overview
? ? ? ? ? ? 12.3.4.2. Financial Overview
? ? ? ? ? ? 12.3.4.3. Product Portfolio
? ? ? ? ? ? 12.3.4.4. Business Strategies
? ? ? ? ? ? 12.3.4.5. Recent Developments
? ? ? ? 12.3.5. Globus Medical
? ? ? ? ? ? 12.3.5.1. Company Overview
? ? ? ? ? ? 12.3.5.2. Financial Overview
? ? ? ? ? ? 12.3.5.3. Product Portfolio
? ? ? ? ? ? 12.3.5.4. Business Strategies
? ? ? ? ? ? 12.3.5.5. Recent Developments
? ? ? ? 12.3.6. Integra Lifesciences Corporation
? ? ? ? ? ? 12.3.6.1. Company Overview
? ? ? ? ? ? 12.3.6.2. Financial Overview
? ? ? ? ? ? 12.3.6.3. Product Portfolio
? ? ? ? ? ? 12.3.6.4. Business Strategies
? ? ? ? ? ? 12.3.6.5. Recent Developments
? ? ? ? 12.3.7. Johnson & Johnson
? ? ? ? ? ? 12.3.7.1. Company Overview
? ? ? ? ? ? 12.3.7.2. Financial Overview
? ? ? ? ? ? 12.3.7.3. Product Portfolio
? ? ? ? ? ? 12.3.7.4. Business Strategies
? ? ? ? ? ? 12.3.7.5. Recent Developments
? ? ? ? 12.3.8. Medtronic plc
? ? ? ? ? ? 12.3.8.1. Company Overview
? ? ? ? ? ? 12.3.8.2. Financial Overview
? ? ? ? ? ? 12.3.8.3. Product Portfolio
? ? ? ? ? ? 12.3.8.4. Business Strategies
? ? ? ? ? ? 12.3.8.5. Recent Developments
? ? ? ? 12.3.9. MTF Biologics
? ? ? ? ? ? 12.3.9.1. Company Overview
? ? ? ? ? ? 12.3.9.2. Financial Overview
? ? ? ? ? ? 12.3.9.3. Product Portfolio
? ? ? ? ? ? 12.3.9.4. Business Strategies
? ? ? ? ? ? 12.3.9.5. Recent Developments
? ? ? ? 12.3.10. NORAKER
? ? ? ? ? ? 12.3.10.1. Company Overview
? ? ? ? ? ? 12.3.10.2. Financial Overview
? ? ? ? ? ? 12.3.10.3. Product Portfolio
? ? ? ? ? ? 12.3.10.4. Business Strategies
? ? ? ? ? ? 12.3.10.5. Recent Developments
? ? ? ? 12.3.11. RTI Surgical
? ? ? ? ? ? 12.3.11.1. Company Overview
? ? ? ? ? ? 12.3.11.2. Financial Overview
? ? ? ? ? ? 12.3.11.3. Product Portfolio
? ? ? ? ? ? 12.3.11.4. Business Strategies
? ? ? ? ? ? 12.3.11.5. Recent Developments
? ? ? ? 12.3.12. Stryker
? ? ? ? ? ? 12.3.12.1. Company Overview
? ? ? ? ? ? 12.3.12.2. Financial Overview
? ? ? ? ? ? 12.3.12.3. Product Portfolio
? ? ? ? ? ? 12.3.12.4. Business Strategies
? ? ? ? ? ? 12.3.12.5. Recent Developments
? ? ? ? 12.3.13. Zimmer Biomet
? ? ? ? ? ? 12.3.13.1. Company Overview
? ? ? ? ? ? 12.3.13.2. Financial Overview
? ? ? ? ? ? 12.3.13.3. Product Portfolio
? ? ? ? ? ? 12.3.13.4. Business Strategies
? ? ? ? ? ? 12.3.13.5. Recent Developments



List of Figures

List of Figures

Figure 01: Global Orthobiologics Market Value (US$ Mn) Forecast, 2017-2031

Figure 02: Global Orthobiologics Market Share Analysis, by Product, 2022

Figure 03: Global Orthobiologics Market Share Analysis, by End-user, 2022

Figure 04: Global Orthobiologics Market Value (US$ Mn) Share Analysis, by Product, 2022 and 2031

Figure 05: Global Orthobiologics Market Share Analysis, by Product, 2022

Figure 06: Global Orthobiologics Market Share Analysis, by Product, 2031

Figure 07: Global Orthobiologics Market Attractiveness Analysis, by Product, 2023-2031

Figure 08: Global Orthobiologics Market Revenue (US$ Mn), by Demineralized Bone Matrix (DBM), 2017-2031

Figure 09: Global Orthobiologics Market Value Share Analysis, by Demineralized Bone Matrix (DBM), 2022 and 2031

Figure 10: Global Orthobiologics Market Revenue (US$ Mn), by Hydroxyapatite (HAp), 2017-2031

Figure 11: Global Orthobiologics Market Value Share Analysis, by Hydroxyapatite (HAp), 2022 and 2031

Figure 12: Global Orthobiologics Market Revenue (US$ Mn), by Hyaluronic acid (HA), 2017-2031

Figure 13: Global Orthobiologics Market Value Share Analysis, by Hyaluronic acid (HA), 2022 and 2031

Figure 14: Global Orthobiologics Market Revenue (US$ Mn), by Calcium Sulfate Matrix, 2017-2031

Figure 15: Global Orthobiologics Market Value Share Analysis, by Calcium Sulfate Matrix, 2022 and 2031

Figure 16: Global Orthobiologics Market Revenue (US$ Mn), by ?-tricalcium phosphate (?-TCP), 2017-2031

Figure 17: Global Orthobiologics Market Value Share Analysis, by ?-tricalcium phosphate (?-TCP), 2022 and 2031

Figure 18: Global Orthobiologics Market Revenue (US$ Mn), by ?-TCP + HAp, 2017-2031

Figure 19: Global Orthobiologics Market Value Share Analysis, by ?-TCP + HAp, 2022 and 2031

Figure 20: Global Orthobiologics Market Revenue (US$ Mn), by DBM + HA, 2017-2031

Figure 21: Global Orthobiologics Market Value Share Analysis, by DBM + HA, 2022 and 2031

Figure 22: Global Orthobiologics Market Revenue (US$ Mn), by ?-TCP + PLGA, 2017-2031

Figure 23: Global Orthobiologics Market Value Share Analysis, by ?-TCP + PLGA, 2022 and 2031

Figure 24: Global Orthobiologics Market Revenue (US$ Mn), by Regenerative medicine, 2017-2031

Figure 25: Global Orthobiologics Market Value Share Analysis, by Regenerative medicine, 2022 and 2031

Figure 26: Global Orthobiologics Market Revenue (US$ Mn), by Growth Factors, 2017-2031

Figure 27: Global Orthobiologics Market Value Share Analysis, by Growth Factors, 2022 and 2031

Figure 28: Global Orthobiologics Market Value (US$ Mn) Share Analysis, by End-user, 2022 and 2031

Figure 29: Global Orthobiologics Market Share Analysis, by End-user, 2022

Figure 30: Global Orthobiologics Market Share Analysis, by End-user, 2031

Figure 31: Global Orthobiologics Market Revenue (US$ Mn), by Hospitals, 2017-2031

Figure 32: Global Orthobiologics Market Value Share Analysis, by Hospitals, 2022 and 2031

Figure 33: Global Orthobiologics Market Revenue (US$ Mn), by Orthopedic Clinics, 2017-2031

Figure 34: Global Orthobiologics Market Value Share Analysis, by Orthopedic Clinics, 2022 and 2031

Figure 35: Global Orthobiologics Market Revenue (US$ Mn), by Others, 2017-2031

Figure 36: Global Orthobiologics Market Value Share Analysis, by Others, 2022 and 2031

Figure 37: Global Orthobiologics Market Value Share Analysis, by Region, 2022 and 2031

Figure 38: Global Orthobiologics Market Attractiveness Analysis, by Region, 2023-2031

Figure 39: India Orthobiologics Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017-2031

Figure 40: India Orthobiologics Market Value Share Analysis, by Product, 2022 and 2031

Figure 41: India Orthobiologics Market Attractiveness Analysis, Product, 2023-2031

Figure 42: India Orthobiologics Market Value Share Analysis, by End-user, 2022 and 2031

Figure 43: India Orthobiologics Market Attractiveness Analysis, End-user, 2023-2031

Figure 44: Europe Orthobiologics Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017-2031

Figure 45: Europe Orthobiologics Market Value Share Analysis, by Country/Sub-region, 2021 and 2031

Figure 46: Europe Orthobiologics Market Attractiveness Analysis, by Country/Sub-region, 2023-2031

Figure 47: Europe Orthobiologics Market Value Share Analysis, by Product, 2022 and 2031

Figure 48: Europe Orthobiologics Market Attractiveness Analysis, Product, 2023-2031

Figure 49: Europe Orthobiologics Market Value Share Analysis, by End-user, 2022 and 2031

Figure 50: Europe Orthobiologics Market Attractiveness Analysis, End-user, 2023-2031

Figure 51: Rest of the World Orthobiologics Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017-2031

Figure 52: Rest of the World Orthobiologics Market Value Share Analysis, by Product, 2022 and 2031

Figure 53: Rest of the World Orthobiologics Market Attractiveness Analysis, Product, 2023-2031

Figure 54: Rest of the World Orthobiologics Market Value Share Analysis, by End-user, 2022 and 2031

Figure 55: Rest of the World Orthobiologics Market Attractiveness Analysis, End-user, 2023-2031

Figure 56: Market Share Analysis by Company (2022)

List of Tables

List of Tables

Table 01: Global Orthobiologics Market Value (US$ Mn) Forecast, by Product, 2017-2031

Table 02: Global Orthobiologics Market Value (US$ Mn) Forecast, by Regenerative Medicine, 2017-2031

Table 03: Global Orthobiologics Market Value (US$ Mn) Forecast, by Growth Factors, 2017-2031

Table 04: Global Orthobiologics Market Value (US$ Mn) Forecast, by End-user, 2017-2031

Table 05: Global Orthobiologics Market Value (US$ Mn) Forecast, by Region, 2017-2031

Table 06: India Orthobiologics Market Value (US$ Mn) Forecast, by Product, 2017-2031

Table 07: India Orthobiologics Market Value (US$ Mn) Forecast, by Regenerative Medicine, 2017-2031

Table 08: India Orthobiologics Market Value (US$ Mn) Forecast, by Growth Factors, 2017-2031

Table 09: India Orthobiologics Market Value (US$ Mn) Forecast, by End-user, 2017-2031

Table 10: Europe Orthobiologics Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2031

Table 11: Europe Orthobiologics Market Value (US$ Mn) Forecast, by Product, 2017-2031

Table 12: Europe Orthobiologics Market Value (US$ Mn) Forecast, by Regenerative Medicine, 2017-2031

Table 13: Europe Orthobiologics Market Value (US$ Mn) Forecast, by Growth Factors, 2017-2031

Table 14: Europe Orthobiologics Market Value (US$ Mn) Forecast, by End-user, 2017-2031

Table 15: Rest of the World Orthobiologics Market Value (US$ Mn) Forecast, by Product, 2017-2031

Table 16: Rest of the World Orthobiologics Market Value (US$ Mn) Forecast, by Regenerative Medicine, 2017-2031

Table 17: Rest of the World Orthobiologics Market Value (US$ Mn) Forecast, by Growth Factors, 2017-2031

Table 18: Rest of the World Orthobiologics Market Value (US$ Mn) Forecast, by End-user, 2017-2031